Highlights Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-07 EDT			5-day change	1st Jan Change
791,000 ^KRW	+0.76%		+1.28%	+4.08%

05-06	Samsung Group Firms Set to Invest in US-based Latus Bio	MT
04-25	Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Samsung Group Firms Set to Invest in US-based Latus Bio	05-06	MT
Samsung Biologics Posts Higher Q1 Profit, Sales	04-25	MT
Samsung Biologics Boosts Contract Size with MSD Switzerland	04-08	MT
Samsung Life Science Fund Invests in Biologics Developer	03-20	MT
Samsung Biologics Strikes $353 Million Deal with Belgium's UCB	03-07	MT
Samsung Biologics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Samsung Biologics Collaborates with LegoChem Biosciences on ADC Development and Manufacturing	02-09	MT
Samsung Biologics's Q4 Net Income Declines	01-24	MT
Samsung C&T Inks Deal with US-Based Flagship Pioneering for Bio Startup Investment	01-09	MT
Samsung Bioepis Enters Joint Research Pact with IntoCell	12-06	MT
Samsung Biologics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Samsung Biologics' Net Profit Jumps 86% in Q3	23-10-26	MT
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma's Portfolio Companies	23-10-23	CI
Samsung Biologics Signs $242 Million Drug Manufacturing Deal	23-09-20	MT
Samsung Biologics Co., Ltd. Announces Expanded Strategic Agreement with Bristol Myers Squibb to Manufacture an Antibody Cancer Drug Substance	23-09-17	CI
Samsung Biologics Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Samsung Biologics' Net Income Rises 22% in Q2, Revenue Beats Estimates	23-07-27	MT
Samsung Biologics Inks $391 Million Production Contract with Novartis	23-07-11	MT
Samsung Biologics Signs Over $411 Million Manufacturing Contract with Pfizer	23-06-09	MT
Samsung Biologics to Begin Operations of New Biomedicine Production Facility in April 2025	23-06-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

Highlights

Filters